Intrahepatic Bile Ducts
Primary Site | Histology | Staging Type |
---|---|---|
C221 | 8000-8159, 8162, 8181-9136, 9141-9582, 9700-9701 | Summary Stage only |
C221 | 8160-8161, 8180 | TNM 7 and Summary Stage |
C220 | 8160-8161, 8180 | Summary Stage only |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C220 Liver C221 Intrahepatic bile duct **Note 1:** This schema is based on the UICC chapter *Liver-Intrahepatic Bile Ducts,* pages 114-117. **Note 2:** For C220, the BileDuctsIntrahepatic schema only includes 8190, 8161, and 8180. For other histologies, see the Liver schema. **Note 3:** For C221, the BileDuctsIntraHepat schema only includes M-8000-8162, 8180-9136, 9141-9582, and 9700-9701. For hepatocellular carcinoma, M-8170-8175, see the Liver schema. **Note 4:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Liver and Intrahepatic Bile Ducts* chapter on page 108 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=108).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | Yes | NAACCR #940 | None | |
Clinical N | <BLANK> | Yes | NAACCR #950 | None | |
Clinical M | <BLANK> | Yes | NAACCR #960 | None | |
TNM Clin Stage Group | 99 | Yes | NAACCR #970 | None | |
Pathologic T | <BLANK> | Yes | NAACCR #880 | None | |
Pathologic N | <BLANK> | Yes | NAACCR #890 | None | |
Pathologic M | <BLANK> | Yes | NAACCR #900 | None | |
TNM Path Stage Group | 99 | Yes | NAACCR #910 | None | |
SSF1: Alpha Fetoprotein (AFP) Interpretation | 999 | No | NAACCR #2880 | CCCR/Canada COC SEER |
None |
SSF2: Fibrosis Score | 988 | No | NAACCR #2890 | CCCR/Canada COC |
None |
SSF3: Alpha Fetoprotein (AFP) Lab Value | 988 | No | NAACCR #2900 | None | None |
SSF11: Primary Sclerosing Cholangitis (PSC) | 988 | No | NAACCR #2865 | CCCR/Canada COC |
None |
SSF12: Carbohydrate Antigen 19-9 (CA 19-9) Lab Value | 988 | No | NAACCR #2866 | None | None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No | NAACCR #390 | None | |
Primary Site | <BLANK> | Yes | NAACCR #400 | None | |
Histology | <BLANK> | Yes | NAACCR #522 | None | |
Behavior | <BLANK> | Yes | NAACCR #523 | None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes | NAACCR #1639 | None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes | NAACCR #1380 | None | |
Regional Nodes Positive | <BLANK> | Yes | NAACCR #820 | None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | 1.1 | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
None |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
None |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
None |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
None |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
None |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
None |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
None |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
None |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
None |
None |